Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.945
+0.015 (0.78%)
At close: Sep 11, 2026, 4:00 PM EDT
1.950
+0.005 (0.26%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $107.7 million as of September 11, 2026. Its market cap has decreased by -11.46% in one year.
Market Cap
107.70M
Enterprise Value
-22.76M
1-Year Change
-11.46%
Ranking
Category
Stock Price
$1.95
ChartMarket Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $107.70M, a decrease of -96.71%. That is a compound annual growth rate of -44.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 107.70M | 4.62% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Conexeu Sciences | 113.72M |
| Vivani Medical | 112.75M |
| Black Diamond Therapeutics | 112.61M |
| Tenax Therapeutics | 111.70M |
| Genelux | 111.13M |
| Aardvark Therapeutics | 109.64M |
| PMV Pharmaceuticals | 108.74M |
| Coya Therapeutics | 106.03M |